CRT-700.36 Dual Antiplatelet Therapy Versus Single Antiplatlet Therapy After Transaortic Valve Replacement: Meta-Analysis

The current American College of Cardiology/American Heart Association (ACC/AHA) recommends empirical therapy with dual antiplatelet (DAPT) regimen of ASA and clopidogrel for six months after aortic valve replacement (TAVR). This recommendation is based on the expert consensus rather than clear